<DOC>
	<DOCNO>NCT02400307</DOCNO>
	<brief_summary>This study evaluate pharmacokinetic ( PK ) profile , safety , tolerability oral GS-9883 adult impair renal function relative match , healthy control normal renal function . Each participant renal impairment group match age ( ± 10 year ) , gender , body mass index [ BMI ( ± 20 % , 18 ≤ BMI ≤ 40 kg/m^2 ) ] participant control group .</brief_summary>
	<brief_title>Pharmacokinetics GS-9883 Adults With Normal Impaired Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>All Individuals : Must calculate BMI 18 40 kg/m^2 , inclusive , screening Individuals impair renal function Chronic stable renal impairment without recent clinical change Mild : Creatinine clearance ( CrCl ) = 60 89 mL/min Moderate : CrCl = 30 59 mL/min Severe : CrCl = 15 29 mL/min Healthy individual CrCl ≥ 90 mL/min All Individuals : Pregnant lactate female HIV positive chronic hepatitis B infected Individuals impair renal function Chronic liver disease Dialysis anticipate use dialysis Renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Renally Impaired</keyword>
</DOC>